Soterix Medical Inc. announces today a new clinical trial for Pediatric Epilepsy supported by the Epilepsy Foundation.
Epilepsy Foundation awards a New Therapy Grant for a clinical trial of High-Definition tDCS in pediatric epilepsy. Dr. Alexander Rotenberg will lead a team of clinical investigators including at Children’s Hospital, Boston and Harvard Medical School. The study will use High-Definition (HD) tDCS to deliver focal inhibitory current and Soterix Medical Custom Solution modeling to optimize targeting.
On June 21, 2012, The Epilepsy Therapy Project (ETP) and the Epilepsy Foundation (EF) announced that Soterix Medical received the New Therapy Grants Program, a unique joint venture of these two non-profit epilepsy organizations to advance clinical development and commercialization of promising epilepsy therapies."The mission of this collaborative grant program is to improve the quality of life for people living with epilepsy in their lifetimes," said Sandy Finucane, Executive Vice President of the Epilepsy Foundation."Epilepsy affects nearly three million people in the United States and 65 million people worldwide. Even with current treatments, close to one third of people with epilepsy live with uncontrolled seizures and there remains an overwhelming need for new treatment options."
Dr. Abhishek Datta, CTO of Soterix Medical summarizes “The Soterix Medical High-Definition tDCS system is the only technology capable of delivering uni-directional hyper-polarizing only targeted stimulation to the brain. This combination of features made HD-tDCS the optimal choice for this trial. In addition, our software systems allow patient specific design of stimulation protocol to account for both individual anatomical differences and seizure focus.” About the Epilepsy Foundation
The Epilepsy Foundation, a national nonprofit with affiliated organizations throughout the United States, has led the fight against epilepsy since 1968. The Foundation's mission is to stop seizures, find cures and overcome the challenges created by epilepsy. For additional information, please visitwww.epilepsyfoundation.org.
About the Epilepsy Therapy Project
The Epilepsy Therapy Project is a 501(c) (3) non-profit organization whose mission is to accelerate ideas into therapies for people living with epilepsy and seizures. Founded in 2002 by a group of parents, distinguished physicians, and researchers, the Epilepsy Therapy Project supports the commercialization of new therapies through direct grants and investments in promising academic and commercial projects. For more information about epilepsy, epilepsy treatment and the epilepsy pipeline, please visit our website, www.epilepsy.com or call 540.687.8077
Media Contact
Narges Ghazi
Email: contact@soterixmedical.com
At Soterix Medical Inc., Engineering Serving Humanity means that we're committed to bring the most advanced medical technology into the hands of people who need it. The commitment underpins everything we do.
